NICE, France, March 23 (UPI) -- Cancer researchers say they have come up with a new breast cancer treatment that can starve tumors of blood and slow the disease.
The findings, to be presented at the annual European Breast Cancer Conference in Nice, France, may be good news for a majority of breast cancer patients who are not suited for the drug Herceptin because of wrong genetic makeup, reports The Times of London.
The new study says a trial involving giving Avastin to those with advanced breast cancer showed the treatment significantly slowed the progression of the disease. The drug is designed to block the transfer of nutrients that feed a tumor, the report said.
The study done by the Eastern Cooperative Oncology Group, a coalition of 6,000 medical professionals in the United States, Canada and South Africa, also suggested that Avastin could eradicate cancers before they spread beyond the breast, The Times reported.
